Verix team (from website)
Verix , an Israeli firm that offers an AI driven commercial optimization platform for the pharmaceutical industry, has acquired Start-Up.ai, a team of AI specialists that helps businesses improve their processes using artificial intelligence and machine learning for an undisclosed sum. Meanwhile, Deepchecks, an Israeli startup that offers a solution to continuously test models from development through production, raised $14 million in a seed investment Alpha Wave Ventures.
Founded in 2019, Deepchecks is an open-source package for Machine Learning validation. The company boasts that its Open Source is a python library for data scientists and ML engineers. The package includes extensive test suites for machine learning models and data, built in a way that’s flexible, extendable and editable.
Start-Up.ai boasts that it provides “all the knowledge needed” for succeeding in AI, from ROI-centric innovation, through rigorous research to engineering robustness and execution.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.
Founded in 2007, Verix offers “timely, focused, and relevant insights” which the firm says is crucial to the success of any business as well as its to influence. Verix’s cloud-based suite of analytic applications was developed specifically for Pharma commercial operations.
Verix boasts that its AI-based COP “Tovana”, is a single, scalable, and agile platform that incorporates a powerful AI/ML engine to provide accurate and timely insights. It is specifically designed for the pharmaceutical industry and comes equipped with pre-built pharma-specific use cases and an automatically refreshing data foundation.
“Verix has been a long-time partner of start-up.ai and we have enjoyed working closely with the company as it has expanded its global footprint and its roster of tier-one pharma manufacturers and life sciences firms,” said Shahar Cohen, co-founder and CEO of start-up.ai. “Verix’s platform is the perfect place for implementing the technology we have spent years developing, allowing us to optimize the way we acquire, process, and utilize large data for the benefit of pharma companies, physicians and patients.”
“In our time working with start-up.ai, we were consistently impressed with their AI capabilities and innovative approach to solving customer challenges,” said Doron Aspitz, CEO of Verix. “As we continue to grow, serving more and more customers, we understand the strategic value of continuing to build out category-leading AI capabilities, which are embedded in our opportunity engine platform “Tovana”. Adding the start-up.ai team to Verix was a natural decision for us and we are excited for what our new capabilities will enable us to deliver to our customers and partners around the world.”
